REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Gp Bionics Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Navigational, Measuring, Electromedical, and Control Instruments Manufacturing | Medical Equipment and Supplies Manufacturing | Rental and Leasing Services | Scientific Research and Development Services | Research and Development in the Social Sciences and Humanities | All Other Professional, Scientific, and Technical Services | Ambulatory Health Care Services | General Medical and Surgical Hospitals
Full name: Gp Bionics Sp. z o.o. Profile Updated: June 03, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Gp Bionics Sp. z o.o. is based in Poland. The head office is in Warsaw. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was established on February 21, 2017. Its’ total assets recorded a growth of 1.38%.

Headquarters
Ul. Augusta Cieszkowskiego 1/3/125
Warsaw; Mazowieckie; Postal Code: 01-636

Contact Details: Purchase the Gp Bionics Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Gp Bionics Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Gp Bionics Sp. z o.o. report to view the information.
Incorporation Date:
February 21, 2017
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Gp Bionics Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-98.77%▼
Net Profit (Loss) for the Period
-98.77%▼
Total assets
1.38%▲
Total equity
-109.56%▼
Return on Equity (ROE)
-2.84%▼
Debt to Equity Ratio
-99.62%▼
Quick Ratio
-1.05%▼
Cash Ratio
-0.01%▼

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Selvita Services Sp. z o.o.
 
Sartorius Stedim Poland Sp. z o.o.
Polpharma Biologics S.A.
 
Ryvu Therapeutics S.A.
Windprojekt Sp. z o.o.
 
Wilandt Institute
Wet-Family Sp. z o.o.
 
Wekzmed Sp. z o.o.
Warsaw Genomics Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo